Vaccine and Vaccination — MCQs

Vaccine and Vaccination Indian Medical PG Practice Questions and MCQs

Question 41: What is one advantage of a live attenuated vaccine?

A. It produces persistent infections.
B. The viral strain can revert to virulent forms.
C. It has an unlimited shelf life.
D. It induces a wide spectrum of antibodies. (Correct Answer)

Explanation: **Explanation:** **1. Why Option D is Correct:** Live attenuated vaccines (LAVs) consist of pathogens that are weakened but still capable of replication within the host. Because the vaccine strain mimics a natural infection, it presents multiple antigens (epitopes) to the immune system. This results in a **broad-based immune response**, inducing a wide spectrum of antibodies (humoral immunity) as well as a robust cell-mediated immune response (T-cell activation). Unlike killed vaccines, LAVs often provide lifelong immunity with a single dose. **2. Why Other Options are Incorrect:** * **Option A:** While the vaccine virus replicates, it is designed *not* to cause persistent or chronic infections in immunocompetent hosts. The goal is a self-limiting subclinical infection. * **Option B:** Reversion to virulence (e.g., VDPV in Oral Polio Vaccine) is a significant **disadvantage** and safety concern of LAVs, not an advantage. * **Option C:** LAVs are highly thermolabile (heat-sensitive) and require a strict **cold chain**. They have a limited shelf life compared to inactivated or subunit vaccines. **High-Yield Clinical Pearls for NEET-PG:** * **Contraindications:** LAVs are generally contraindicated in **pregnancy** and **immunocompromised** individuals (risk of uncontrolled replication). * **The "Rule of 4 Weeks":** If two live parenteral vaccines (e.g., MMR and Varicella) are not given on the same day, they should be spaced at least 4 weeks apart to prevent immune interference. * **Examples of LAVs:** BCG, OPV (Sabin), MMR, Varicella, Yellow Fever, and Intranasal Influenza. * **Smallpox Vaccine:** The only vaccine consisting of a live virus (Vaccinia) that is not the actual pathogen (Variola) but provides cross-protection.

Question 42: Following immunization with the hepatitis B vaccine, which of the following is typically detected in the serum?

A. Hepatitis B e antigen (HBeAg)
B. Fetal bovine serum (FBS) antigen
C. Anti-HBs antibody (Correct Answer)
D. Anti-HBe antibody

Explanation: ### Explanation **Correct Answer: C. Anti-HBs antibody** **Why it is correct:** The Hepatitis B vaccine is a **subunit recombinant vaccine** containing the purified **Hepatitis B surface antigen (HBsAg)**. It is produced by inserting the gene for HBsAg into *Saccharomyces cerevisiae* (yeast cells). When injected, the body recognizes HBsAg as foreign and mounts a humoral immune response, leading to the production of **Anti-HBs antibodies**. The presence of these antibodies (typically >10 mIU/mL) indicates protective immunity against the virus. **Why the other options are incorrect:** * **HBeAg (Option A):** This is a marker of active viral replication and high infectivity. It is produced during an actual infection, not by the vaccine. * **Fetal bovine serum (FBS) antigen (Option B):** While FBS may be used in some cell culture media during vaccine manufacturing, it is a contaminant/growth medium component, not the intended immunogenic product detected in serum post-vaccination. * **Anti-HBe antibody (Option C):** These antibodies develop after the clearance of HBeAg during a natural infection, signaling a transition to a lower infectivity state. They are not produced by the HBsAg-only vaccine. **High-Yield Clinical Pearls for NEET-PG:** * **Marker of Vaccination:** Anti-HBs (+) and Anti-HBc (–). * **Marker of Past Infection:** Anti-HBs (+) and Anti-HBc (+). * **Non-responders:** Individuals who fail to develop an adequate antibody titer (>10 mIU/mL) after two full courses of the vaccine. * **Site of Injection:** Intramuscular in the **deltoid muscle** (adults) or anterolateral thigh (infants). It should never be given in the gluteal region due to lower immunogenicity (fat interferes with processing). * **Schedule:** 0, 1, and 6 months.

Question 43: Which statement is NOT true regarding the measles vaccine?

A. It is grown in egg culture. (Correct Answer)
B. It is available in a freeze-dried form.
C. The reconstituted vaccine must be used within one hour.
D. It is administered after 9 months of age.

Explanation: The measles vaccine is a live-attenuated vaccine (Edmonston-Zagreb strain) that is a staple of the Universal Immunization Programme (UIP). **Explanation of the Correct Answer:** * **Option A (Incorrect Statement):** The measles vaccine is **not** grown in egg culture. It is prepared using **Chick Embryo Fibroblast (CEF) cell cultures**. While it uses cells derived from embryos, it is distinct from "egg culture" (like the Influenza or Yellow Fever vaccines). This is a high-yield distinction for exams. **Analysis of Other Options:** * **Option B (True):** The vaccine is supplied in a **freeze-dried (lyophilized)** form to maintain stability. It must be stored between +2°C to +8°C and protected from light. * **Option C (True):** Once reconstituted with the provided diluent (Sterile Water for Injection), the vaccine is highly thermolabile and prone to bacterial contamination. It must be used within **4 to 6 hours** (though many guidelines emphasize "as soon as possible," and the 1-hour mark is often used as a safety threshold in specific clinical contexts; however, in the context of this MCQ, Option A is the definitive false statement). * **Option D (True):** In India, the first dose is administered at **9 completed months**. Administering it earlier is avoided because maternal antibodies can neutralize the vaccine virus, rendering it ineffective. **NEET-PG High-Yield Pearls:** * **Strain:** Edmonston-Zagreb (most common in India). * **Route:** Subcutaneous (0.5 ml). * **Side Effect:** Toxic Shock Syndrome (TSS) can occur if the reconstituted vaccine is kept for too long due to *Staphylococcus aureus* contamination. * **Contraindication:** Severe immunosuppression (e.g., advanced HIV), but **not** egg allergy (since it is grown in fibroblast culture, not egg protein).

Question 44: In which of the following scenarios is the pneumococcal vaccine most effective?

A. When given preoperatively (Correct Answer)
B. When given postoperatively
C. Against all strains of Streptococcus pneumoniae
D. Against Gram-negative bacteria

Explanation: ### Explanation **1. Why "Preoperatively" is the Correct Answer:** The pneumococcal vaccine is a critical component of **postsplenectomy prophylaxis**. The spleen is the primary site for clearing opsonized encapsulated bacteria (like *Streptococcus pneumoniae*) from the bloodstream. When an elective splenectomy is planned, the vaccine should ideally be administered **at least 2 weeks before surgery**. The underlying medical concept is **immunological priming**: giving the vaccine preoperatively allows the body to mount a robust antibody response while the spleen is still functional. This ensures that protective levels of antibodies are already circulating before the patient enters an asplenic (immunocompromised) state, significantly reducing the risk of **Overwhelming Post-Splenectomy Infection (OPSI)**. **2. Why the Other Options are Incorrect:** * **Option B (Postoperatively):** If the vaccine cannot be given before surgery, it is given 2 weeks after. However, the immune response is generally less optimal than the preoperative approach. In emergency splenectomy (e.g., trauma), it is delayed for 14 days to allow the patient to recover from the initial surgical stress. * **Option C (Against all strains):** This is incorrect. The Pneumococcal Polysaccharide Vaccine (PPSV23) covers 23 serotypes, and the Conjugate Vaccine (PCV13/20) covers fewer. There are over 90 known serotypes of *S. pneumoniae*. * **Option D (Against Gram-negative bacteria):** *Streptococcus pneumoniae* is a **Gram-positive coccus**. While asplenic patients are also at risk from *H. influenzae* and *N. meningitidis* (Gram-negative), the pneumococcal vaccine specifically targets the Gram-positive pneumococcus. **3. Clinical Pearls for NEET-PG:** * **The "Big Three" Vaccines for Splenectomy:** *S. pneumoniae*, *H. influenzae* type b (Hib), and *N. meningitidis*. * **Timing:** Best given >14 days before elective surgery or >14 days after emergency surgery. * **Most Common Cause of OPSI:** *Streptococcus pneumoniae* (responsible for ~50-90% of cases). * **Drug of Choice for Prophylaxis:** Oral Penicillin V is often used as daily prophylaxis in children post-splenectomy.

Question 45: Guillain-Barré syndrome can be seen following which type of immunization?

A. Pertussis
B. Measles
C. Diphtheria
D. Killed Influenza vaccine (Correct Answer)

Explanation: ### Explanation **Correct Option: D. Killed Influenza vaccine** Guillain-Barré Syndrome (GBS) is an acute inflammatory demyelinating polyneuropathy. The association between GBS and the influenza vaccine was first significantly noted during the 1976 Swine Flu (H1N1) vaccination campaign. While the absolute risk is extremely low (approximately 1–2 additional cases per million doses), it remains a classic association in medical literature and exams. The underlying mechanism is believed to be **molecular mimicry**, where the immune response against vaccine antigens cross-reacts with gangliosides in the peripheral nerves. **Analysis of Incorrect Options:** * **A. Pertussis:** The Whole-cell Pertussis (wP) vaccine is more commonly associated with febrile seizures and, historically, a controversial link to encephalopathy, but not GBS. * **B. Measles:** Measles vaccination is associated with a rare risk of Subacute Sclerosing Panencephalitis (SSPE)-like symptoms in immunocompromised individuals or idiopathic thrombocytopenic purpura (ITP), but GBS is not a standard complication. * **C. Diphtheria:** Diphtheria toxoid is generally considered safe; while the diphtheria *infection* can cause neuropathy (via exotoxin), the vaccine is not a recognized trigger for GBS. **High-Yield Clinical Pearls for NEET-PG:** * **Most common antecedent infection for GBS:** *Campylobacter jejuni* (presents with bloody diarrhea). * **Other associated vaccines:** Oral Polio Vaccine (OPV) and Rabies vaccine (Neural tissue derived - Semple vaccine) have historical associations with neurological complications. * **Key CSF Finding in GBS:** **Albuminocytologic dissociation** (High protein with normal cell count). * **Treatment of choice:** Intravenous Immunoglobulin (IVIG) or Plasmapheresis. Steroids are generally not effective.

Question 46: What type of vaccine is the MMR vaccine?

A. Live attenuated
B. Killed (Correct Answer)
C. Toxoid
D. Subunit

Explanation: **Explanation:** The **MMR vaccine** (Measles, Mumps, and Rubella) is a classic example of a **Live Attenuated Vaccine**. It consists of live viruses that have been weakened (attenuated) in a laboratory so they can replicate and induce a robust immune response without causing the actual disease in healthy individuals. *Note: There appears to be a discrepancy in the provided key; medically and academically, MMR is universally classified as a Live Attenuated vaccine.* **Analysis of Options:** * **Live Attenuated (Correct Concept):** These vaccines trigger both humoral (B-cell) and cell-mediated (T-cell) immunity, often providing lifelong protection with one or two doses. Examples include MMR, Varicella, BCG, and Oral Polio (Sabin). * **Killed (Inactivated):** These contain microorganisms killed by heat or chemicals (e.g., Formalin). They are safer for immunocompromised patients but usually require booster doses (e.g., IPV, Hepatitis A, Rabies). * **Toxoid:** These are made from inactivated bacterial toxins (e.g., Tetanus and Diphtheria). * **Subunit:** These contain only specific fragments of the pathogen (e.g., Hepatitis B surface antigen, HPV). **High-Yield Clinical Pearls for NEET-PG:** * **Route:** MMR is administered **Subcutaneously (SC)**. * **Schedule:** 1st dose at 9–12 months (as MR in India's NIS) and 2nd dose at 16–24 months. * **Contraindications:** Pregnancy (due to theoretical risk of Congenital Rubella Syndrome) and severely immunocompromised states (HIV with CD4 <200). * **Storage:** It is highly heat-sensitive and must be stored at **2°C to 8°C**, protected from light.

Question 47: The acellular pertussis vaccine contains which of the following components?

A. Pertactin, filamentous hemagglutinin, pertussis toxin, endotoxin
B. Pertactin, filamentous hemagglutinin, fimbriae, endotoxin
C. Pertactin, pertussis toxin, fimbriae
D. Filamentous hemagglutinin, pertussis toxin, fimbriae (Correct Answer)

Explanation: **Explanation:** The **Acellular Pertussis (aP) vaccine** was developed to reduce the high rate of adverse reactions (like fever and febrile seizures) associated with the Whole-cell Pertussis (wP) vaccine. While the wP vaccine contains the entire killed *Bordetella pertussis* organism, the aP vaccine contains only specific, purified immunogenic proteins. **Why Option D is Correct:** The acellular vaccine typically consists of 1 to 5 highly purified antigens. The most common components include: 1. **Pertussis Toxin (PT):** Inactivated toxin that induces neutralizing antibodies. 2. **Filamentous Hemagglutinin (FHA):** A protein required for adhesion to ciliated respiratory epithelial cells. 3. **Fimbriae (Types 2 and 3):** Surface proteins involved in colonization. 4. **Pertactin (PRN):** An outer membrane protein that aids in attachment. **Analysis of Incorrect Options:** * **Options A & B:** These are incorrect because they include **Endotoxin (Lipopolysaccharide/LPS)**. LPS is a component of the Gram-negative cell wall and is the primary cause of the systemic toxicity and reactogenicity (fever, pain) seen in the whole-cell vaccine. It is strictly excluded from acellular preparations. * **Option C:** While it contains valid components, Option D is a more comprehensive representation of the standard multi-component aP vaccines used in DTaP formulations. **High-Yield Clinical Pearls for NEET-PG:** * **DTaP vs. Tdap:** DTaP (higher antigen dose) is used for primary immunization in children <7 years. Tdap (reduced antigen dose) is used as a booster for adolescents and adults. * **Safety:** aP vaccines have a significantly lower risk of **encephalopathy** and **hypotonic-hyporesponsive episodes (HHE)** compared to wP vaccines. * **Efficacy:** While safer, aP vaccines may have a shorter duration of immunity compared to the whole-cell version, leading to the need for regular boosters.

Question 48: Which of the following is not a live vaccine?

A. BCG
B. Hepatitis B (Correct Answer)
C. Oral polio vaccine
D. MMR

Explanation: **Explanation:** The correct answer is **Hepatitis B** because it is a **subunit (recombinant) vaccine**, not a live-attenuated vaccine. It is produced by inserting the gene for the Hepatitis B surface antigen (HBsAg) into yeast cells (*Saccharomyces cerevisiae*), which then produce the antigen used to stimulate immunity. **Analysis of Options:** * **BCG (Bacillus Calmette-Guérin):** A live-attenuated vaccine derived from *Mycobacterium bovis*. It is the standard vaccine for tuberculosis. * **Oral Polio Vaccine (Sabin):** A live-attenuated vaccine containing three types of poliovirus. It induces both systemic (IgG) and local mucosal (IgA) immunity. (Note: The Salk vaccine is the *inactivated*/killed version). * **MMR (Measles, Mumps, Rubella):** A classic live-attenuated combination vaccine. **High-Yield Clinical Pearls for NEET-PG:** 1. **Mnemonic for Live Vaccines:** "**B**oy **R**omeo **G**ive **M**y **L**ove **S**picy **V**ictory **T**onight" (**B**CG, **R**otavirus, **G**OPV/Sabin, **M**MR, **L**ive Typhoid/Ty21a, **S**mallpox, **V**aricella/Yellow Fever, **T**ularemia). 2. **Contraindications:** Live vaccines are generally contraindicated in **pregnancy** and **immunocompromised** individuals (except BCG/OPV in asymptomatic HIV in some guidelines, though generally avoided if CD4 counts are very low). 3. **Hepatitis B Schedule:** Usually given at 0, 1, and 6 months. It is the first vaccine given at birth. 4. **Storage:** Most live vaccines are heat-sensitive and must be stored in the cold chain (usually +2°C to +8°C), while OPV is stored at -20°C for long-term stability.

Question 49: What is the strain used for the production of the Measles vaccine?

A. Jeryl Lynn strain
B. 17-D strain
C. Ankara strain
D. Edmonston Zagreb strain (Correct Answer)

Explanation: **Explanation:** The **Edmonston-Zagreb (EZ) strain** is the most widely used strain for the production of the Measles vaccine globally, including in India (produced by the Serum Institute). It is a live-attenuated vaccine derived from the original Edmonston strain but further adapted in human diploid cells (WI-38). This strain is preferred because it is highly immunogenic and can induce seroconversion even in the presence of low levels of maternal antibodies, making it suitable for administration in infants. **Analysis of Incorrect Options:** * **A. Jeryl Lynn strain:** This is the live-attenuated strain used for the **Mumps** vaccine (part of the MMR/MMRV combination). * **B. 17-D strain:** This is the specific attenuated strain used for the **Yellow Fever** vaccine. It is grown in chick embryos. * **C. Ankara strain:** Specifically the "Modified Vaccinia Ankara" (MVA) strain, it was used in the development of **Smallpox** vaccines and currently serves as a vector for various recombinant vaccines (e.g., Ebola). **High-Yield Clinical Pearls for NEET-PG:** * **Measles Vaccine Timing:** Under the National Immunization Schedule (NIS) in India, the 1st dose is given at **9 completed months** (subcutaneous) and the 2nd dose at **16–24 months**. * **Reconstitution:** The vaccine is lyophilized (freeze-dried) and must be reconstituted with **Sterile Water**. Once reconstituted, it must be used within **4 hours**; otherwise, it must be discarded due to the risk of *Staphylococcus aureus* contamination and Toxic Shock Syndrome. * **Contraindication:** Being a live vaccine, it is contraindicated in pregnancy and severely immunocompromised individuals.

Question 50: Which of the following diseases are being targeted by developing novel vaccine technologies such as CTL inducing vaccines, Recombinant Adeno-associated Virus Vaccine (rAAV), and Modified Vaccinia Ankara (MVA)?

A. Tuberculosis
B. HIV/AIDS (Correct Answer)
C. Malaria
D. Leprosy

Explanation: ### Explanation **Correct Answer: B. HIV/AIDS** The development of vaccines for HIV/AIDS is uniquely challenging because the virus integrates into the host genome and exhibits extreme genetic diversity. Traditional approaches (like killed or live-attenuated vaccines) are either ineffective or pose significant safety risks. Therefore, researchers are utilizing **novel vaccine platforms**: 1. **CTL Inducing Vaccines:** These aim to stimulate **Cytotoxic T-Lymphocytes (CD8+ T-cells)** to recognize and kill virally infected cells, a crucial mechanism for controlling HIV replication. 2. **Viral Vectors (rAAV and MVA):** * **Modified Vaccinia Ankara (MVA):** A highly attenuated strain of vaccinia virus that acts as a safe delivery vehicle for HIV antigens. * **Recombinant Adeno-associated Virus (rAAV):** Used to deliver genes that encode for broadly neutralizing antibodies (bNAbs) or viral proteins to induce long-term immunity. --- ### Why the other options are incorrect: * **A. Tuberculosis:** While new TB vaccines (like M72/AS01E) are in trials, the primary focus remains on improving BCG or developing subunit vaccines. The specific combination of rAAV and MVA-based CTL induction is most characteristic of HIV research. * **C. Malaria:** Malaria vaccine research (e.g., RTS,S/AS01 or R21/Matrix-M) primarily focuses on targeting the circumsporozoite protein to prevent liver-stage infection, rather than utilizing rAAV vectors. * **D. Leprosy:** Leprosy is primarily managed with Multi-Drug Therapy (MDT). Vaccine research is limited, often involving BCG or killed *M. leprae* (ICRC vaccine), rather than high-tech viral vector platforms. --- ### High-Yield Clinical Pearls for NEET-PG: * **MVA (Modified Vaccinia Ankara)** is also a key component in the **Jynneos** vaccine used for Mpox and Smallpox. * **Prime-Boost Strategy:** Many HIV trials use a "DNA prime" followed by a "Viral Vector boost" (like MVA) to maximize the T-cell response. * **The "Berlin Patient"** remains a landmark case in HIV research, representing the first functional cure via CCR5-delta 32 stem cell transplant, though vaccines remain the goal for global control.

Practice by Chapter

Principles of Immunization

Practice Questions

Types of Vaccines

Practice Questions

Vaccine Development and Production

Practice Questions

Routine Immunization Schedule

Practice Questions

Adverse Events Following Immunization

Practice Questions

Cold Chain and Vaccine Delivery

Practice Questions

New Vaccine Technologies

Practice Questions

Vaccination in Special Populations

Practice Questions

Herd Immunity and Population Protection

Practice Questions

Anti-vaccination Movement and Hesitancy

Practice Questions

National Immunization Programs

Practice Questions

Future of Vaccines

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free